A research study published in Diabetes Care found that an intensive weight management program helped more than half of participants with recently diagnosed type 2 diabetes achieve remission after one year.
Trending News
FDA Approves First-of-Its-Kind Chronic Hepatitis B Treatment
For Immediate Release: October 20, 2026 The U.S. Food and Drug Administration today approved Hibsago (bepirovirsen) injection, in combination with existing antiviral therapy, to treat chronic hepatitis B virus (HBV) infection in certain adults without cirrhosis. Hibsago is the first FDA-approved antisense oligonucleotide to treat chronic hepatitis B. Hibsago is...
VEPPANU: A New FDA-Approved Treatment for Advanced Breast Cancer
VEPPANU is prescribed for adults with estrogen receptor-positive (ER-positive), HER2-negative, ESR1-mutated advanced or metastatic breast cancer whose disease has progressed after at least one type of hormone therapy.
FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women
For Immediate Release: October 20, 2026 The U.S. Food and Drug Administration yesterday approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus applied once a week. The approval aligns with FDA’s Public Health Pillar: Increasing Access...
The First Wearable Device That Continuously Monitors Both Ketone Levels and Blood Sugar is Approved
The U.S. Food and Drug Administration today authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for people aged 2 years and older living with diabetes. The Libre Duo 10 Day is the first wearable device in the U.S. that continuously monitors ketone levels, and the first in the world to continuously monitor both ketones and blood sugar...
The Hidden Long-Term Effects of Chemotherapy in Older Breast Cancer Survivors
Thanks to advances in breast cancer treatment, more women are living longer after their diagnosis than ever before. But as survival rates improve, researchers are paying closer attention to what happens after treatment ends. For many survivors, the effects of chemotherapy do not disappear when the last infusion is completed. A recent study examined older breast...